Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The variable plasma quercetin response to 12-week quercetin supplementation in humans

Abstract

Background/Objectives:

Quercetin supplementation results in a variable plasma quercetin response in humans. The purpose of this study was to determine whether this variance is related to gender, age, body mass index (BMI), and other demographic and lifestyle factors.

Subjects/Methods:

Subjects (N=1002, ages 18–85 years, 60% female and 40% male) were recruited from the community and randomized to one of three groups, with supplements administered using double-blinded procedures: Q-500 (500 mg/day), Q-1000 (1000 mg/day), or placebo. Subjects ingested two soft chew supplements twice daily during the 12-week study. Fasting blood samples were obtained pre- and post-study, analyzed for plasma quercetin, and then compared between and within groups by gender, age group (<40, 40–59, and 60 years), BMI (<25, 25–29.9, and 30 kg/m2), self-reported physical fitness level, and diet intake (food group servings).

Results:

Quercetin supplementation over 12 weeks caused a significant increase in overnight-fasted plasma quercetin, with a net increase of 332±21.0 and 516±30.8 μg/l for Q-500 and Q-1000 compared with 53.6±6.4 μg/l for placebo (interaction effect, P<0.001). The increase in plasma quercetin was highly variable within each quercetin supplementation group, but was unrelated to age, gender, BMI, fitness levels, or diet intake.

Conclusions:

In summary, quercetin supplementation in doses of 500 and 1000 mg/day caused large but highly variable increases in plasma quercetin that were unrelated to demographic or lifestyle factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2

Similar content being viewed by others

References

  • Barnes S (2008). Nutritional genomics, polyphenols, diets, and their impact on dietetics. J Am Diet Assoc 108, 1888–1895.

    Article  CAS  Google Scholar 

  • Boots AW, Haenen GR, Bast A (2008a). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585, 325–337.

    Article  CAS  Google Scholar 

  • Boots AW, Wilms LC, Swennen ELR, Kleinjans JCS, Bast A, Haenen G (2008b). In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24, 703–710.

    Article  CAS  Google Scholar 

  • Boyle SP, Dobson VL, Duthie SJ, Hinselwood DC, Kyle JAM, Collins AR (2000). Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. Eur J Clin Nutr 54, 774–782.

    Article  CAS  Google Scholar 

  • Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ (1998). Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 128, 593–597.

    Article  CAS  Google Scholar 

  • Davis JM, Murphy EA, Carmichael MD, Davis B (2009). Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296, R1071–R1077.

    Article  CAS  Google Scholar 

  • Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A et al. (2001). Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133, 117–124.

    Article  CAS  Google Scholar 

  • Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T (2007). Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137, 2405–2411.

    Article  CAS  Google Scholar 

  • Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S et al. (2009). Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102, 1065–1074.

    Article  CAS  Google Scholar 

  • Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J et al. (2008). Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138, 1615–1621.

    Article  CAS  Google Scholar 

  • Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J et al. (2000). Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacoly 56, 545–553.

    Article  CAS  Google Scholar 

  • Goldberg DA, Yan J, Soleas GJ (2003). Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36, 79–87.

    Article  CAS  Google Scholar 

  • Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M (2006). The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res 26, 1177–1181.

    CAS  PubMed  Google Scholar 

  • Hanasaki Y, Ogawa S, Fukui S (1994). The correlation between active pxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16, 845–850.

    Article  CAS  Google Scholar 

  • Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276–1282.

    Article  CAS  Google Scholar 

  • Lee ES, Lee HE, Shin JY, Yoon S, Moon JO (2003). The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats. J Pharm Pharmacol 55, 1169–1174.

    Article  CAS  Google Scholar 

  • Lee RD, Nieman DC (2010). Nutritional Assessment. (5th edn) St Louis: Mosby.

    Google Scholar 

  • Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA et al. (2008). Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 75, 1045–1053.

    Article  CAS  Google Scholar 

  • Lotito SB, Frei B (2006). Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41, 1727–1746.

    Article  CAS  Google Scholar 

  • Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F et al. (1998). Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331–336.

    Article  CAS  Google Scholar 

  • Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S–242S.

    Article  CAS  Google Scholar 

  • Nieman DC, Henson DA, Davis JM, Murphy EA, Jenkins DP, Gross SJ et al. (2007a). Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103, 1728–1735.

    Article  CAS  Google Scholar 

  • Nieman DC, Henson DA, Davis M, Dumke CL, Gross SJ, Jenkins DP et al. (2007b). Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States Endurance Run. J Interferon Cytokine Res 27, 1003–1011.

    Article  CAS  Google Scholar 

  • Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA et al. (2007c). Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 39, 1561–1569.

    Article  CAS  Google Scholar 

  • Nieman DC, Henson DA, Maxwell KR, Williams AS, McAnulty SR, Jin F et al. (2009). Effects of quercetin and EGCG on mitochondrial biogenesis and immunity. Med Sci Sports Exerc 41, 1467–1475.

    Article  CAS  Google Scholar 

  • Read MA (1995). Flavonoids: naturally occurring anti-inflammatory agents. Am J Pathol 147, 235–237.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work is funded by Coca-Cola and Quercegen Pharma.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D C Nieman.

Ethics declarations

Competing interests

DC Nieman holds a position on the science advisory board for Quercegen Pharma. The remaining authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, F., Nieman, D., Shanely, R. et al. The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur J Clin Nutr 64, 692–697 (2010). https://doi.org/10.1038/ejcn.2010.91

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.91

Keywords

Search

Quick links